There is something lurking in the water! Scientist working on the Journey into Midnight mission funded by the National Oceanic and Atmospheric Administration recorded a giant squid about 100 miles off the coast of New Orleans. A robotic camera located the 10-12 foot long creature at a depth of 759 meters (2,490 feet.) At one point one of its tentacles reaches out and hugs the camera, Yikes! App users click here to see the video. This is the only the second time a giant squid has been seen and the first time in U.S. waters. The first giant squid was recorded off the coast of Japan in 2012. Scientist Nathan Robinson said seeing something like this makes “You feel very alive!” “It’s not some exotic creature found thousands of miles away in some unknown deep. It’s our animal,” another expedition scientist, Sonke Johnsen said, “And I think that’s what we as explorers do — we point a finger down into the deep and say this is here, this is amazing and it’s beautiful and it’s something we should care about.”
Tulsa police are taking heat online after a few Facebook posts claim officers in the video below were racially profiling when they made contact with four juvenile females on June 17th. Watch the bodycam footage here The department wants feedback, but asks that comments remain civil.
A head injury, stroke or brain tumor could cause dementia. But did you know your prescribed medication could put you at risk, too? >> Read more trending news Researchers from the University of Nottingham in the United Kingdom recently conduced a study, published in JAMA Internal Medicine, to explore the link between a certain class of drugs and the memory loss condition. To do so, they used QResearch, a large database of anonymized health records, to examine nearly 285,000 adults in the U.K., aged 55 and older, between 2004 and 2016. The team then reviewed each subject’s prescription records to determine their exposure to anticholinergics, which can include antidepressants, bladder antimuscarinics, antipsychotics and antiepileptic drugs. >> Related: Common painkillers triple side effects of dementia, study says After analyzing the results, they found those on anticholinergic medications had almost a 50% increased chance of developing dementia, compared to those who didn’t have prescriptions for anticholinergic drugs. The risk was only associated with 1,095 daily doses within a 10-year period, which is equivalent to an older adult taking a strong anticholinergic medication daily for at least three years. “The study is important because it strengthens a growing body of evidence showing that strong anticholinergic drugs have long term associations with dementia risk,” coauthor Carol Coupland told CNN. “It also highlights which types of anticholinergic drugs have the strongest associations. This is important information for physicians to know when considering whether to prescribe these drugs.” Although the authors said “no firm conclusions can be drawn about whether these anticholinergic drugs cause dementia,” they hope their findings can help professionals better understand the disease. They also advised patients to not stop taking their medications until consulting with their doctor. >> Related: Rate of dementia deaths in US has more than doubled, CDC says As for antihistamines, skeletal muscle relaxants, gastrointestinal antispasmodics, antiarrhythmics, or antimuscarinic bronchodilators, the scientists noted there were no significant dementia risks associated with them.